Association between PPAR-γ 32 Pro12Ala genotype and insulin resistance is modified by circulating lipids in Mexican children

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Stryjecki, Carolina ^a   Peralta Romero, Jesus ^b   Alyass, Akram ^a   Karam Araujo, Roberto ^b   Suarez, Fernando ^b   Gomez Zamudio, Jaime ^c   Burguete Garcia, Ana ^d   Cruz, Miguel ^b   Meyre, David ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b HOSPITAL DE ESPECIALIDADES   (Mexico)

^c INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^d INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

LIPID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

BLOOD; CHILD; COMPLICATION; DYSLIPIDEMIA; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HUMAN; INSULIN RESISTANCE; MEXICO; OBESITY;

CHILD; DYSLIPIDEMIAS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INSULIN RESISTANCE; LIPIDS; MEXICO; OBESITY; PPAR GAMMA;

EID: 84963831448     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep24472     Document Type: Article

References (45)

1. Qi, Q. & Hu, F. B. Genetics of type 2 diabetes in European populations. J. Diabetes 4, 203-212, doi: 10.1111/j.1753-0407.2012.00224.x (2012).
2. Deeb, S. S. et al. A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nat. Genet. 20, 284-287 (1998).
3. Gouda, H. N. et al. The association between the peroxisome proliferator-Activated receptor-gamma2 (PPARG2) Pro12Ala gene variant and type 2 diabetes mellitus: a HuGE review and meta-Analysis. Am. J. Epidemiol. 171, 645-655, doi: 10.1093/aje/kwp450 (2010).
4. Morris, A. P. et al. Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat. Genet. 44, 981-990, doi: 10.1038/ng.2383 (2012).
5. Galbete, C. et al. Pro12Ala variant of the PPARG2 gene increases body mass index: An updated meta-Analysis encompassing 49,092 subjects. Obesity (Silver Spring) 21, 1486-1495, doi: 10.1002/oby.20150 (2013).
6. Robitaille, J., Despres, J. P., Perusse, L. & Vohl, M. C. The PPAR-gamma P12A polymorphism modulates the relationship between dietary fat intake and components of the metabolic syndrome: results from the Quebec Family Study. Clin. Genet. 63, 109-116 (2003).
7. Garaulet, M., Smith, C. E., Hernandez-Gonzalez, T., Lee, Y. C. & Ordovas, J. M. PPARgamma Pro12Ala interacts with fat intake for obesity and weight loss in a behavioural treatment based on the Mediterranean diet. Mol. Nutr. Food Res. 55, 1771-1779, doi: 10.1002/mnfr.201100437 (2011).
8. Luan, J. et al. Evidence for gene-nutrient interaction at the PPARgamma locus. Diabetes 50, 686-689 (2001).
9. Heikkinen, S. et al. The Pro12Ala PPARgamma2 variant determines metabolism at the gene-environment interface. Cell Metab. 9, 88-98, doi: 10.1016/j.cmet.2008.11.007 (2009).
10. Lamri, A. et al. Dietary fat intake and polymorphisms at the PPARG locus modulate BMI and type 2 diabetes risk in the D.E.S.I.R. prospective study. Int. J. Obes. (Lond.) 36, 218-224, doi: 10.1038/ijo.2011.91 (2012).
11. Razquin, C. et al. The Mediterranean diet protects against waist circumference enlargement in 12Ala carriers for the PPARgamma gene: 2 years' follow-up of 774 subjects at high cardiovascular risk. Br. J. Nutr. 102, 672-679, doi: 10.1017/S0007114509289008 (2009).
12. Ylonen, S. K. et al. The Pro12Ala polymorphism of the PPAR-gamma2 gene affects associations of fish intake and marine n-3 fatty acids with glucose metabolism. Eur. J. Clin. Nutr. 62, 1432-1439, doi: 10.1038/sj.ejcn.1602882 (2008).
13. Soriguer, F. et al. Pro12Ala polymorphism of the PPARG2 gene is associated with type 2 diabetes mellitus and peripheral insulin sensitivity in a population with a high intake of oleic acid. J. Nutr. 136, 2325-2330 (2006).
14. Food and Agriculture Organization of the United Nations, The state of food and agriculture. (2013) Available at: http://www.fao.org/docrep/018/i3300e/i3300e00.htm. (Accessed: 4th April 2015).
15. Reynoso-Noveron, N. et al. Estimated incidence of cardiovascular complications related to type 2 diabetes in Mexico using the UKPDS outcome model and a population-based survey. Cardiovasc. Diabetol. 10, 1, doi: 10.1186/1475-2840-10-1 (2011).
16. Gutiérrez, J. P. et al. Encuesta Nacional de Salud y Nutrición 2012. Resultados Nacionales. Cuernavaca, México: Instituto Nacional de Salud Pública. (2012).
17. Parsons, T. J., Power, C., Logan, S. & Summerbell, C. D. Childhood predictors of adult obesity: a systematic review. Int. J. Obes. Relat. Metab. Disord. 23 Suppl 8, S1-107 (1999).
18. Canizales-Quinteros, S. et al. Association of PPARG2 Pro12Ala variant with larger body mass index in Mestizo and Amerindian populations of Mexico. Hum. Biol. 79, 111-119 (2007).
19. Cole, S. A. et al. The Pro12Ala variant of peroxisome proliferator-Activated receptor-gamma2 (PPAR-gamma2) is associated with measures of obesity in Mexican Americans. Int. J. Obes. Relat. Metab. Disord. 24, 522-524 (2000).
20. Martinez-Gomez, L. E. et al. A replication study of the IRS1, CAPN10, TCF7L2, and PPARG gene polymorphisms associated with type 2 diabetes in two different populations of Mexico. Ann. Hum. Genet. 75, 612-620, doi: 10.1111/j.1469-1809.2011.00668.x (2011).
21. Gamboa-Melendez, M. A. et al. Contribution of common genetic variation to the risk of type 2 diabetes in the Mexican Mestizo population. Diabetes 61, 3314-3321, doi: 10.2337/db11-0550 (2012).
22. Cruz, M. et al. Candidate gene association study conditioning on individual ancestry in patients with type 2 diabetes and metabolic syndrome from Mexico City. Diabetes Metab. Res. Rev. 26, 261-270, doi: 10.1002/dmrr.1082 (2010).
23. Black, M. H. et al. Evidence of interaction between PPARG2 and HNF4A contributing to variation in insulin sensitivity in Mexican Americans. Diabetes 57, 1048-1056, doi: 10.2337/db07-0848 (2008).
24. Vidal-Puig, A. et al. Regulation of PPAR gamma gene expression by nutrition and obesity in rodents. J. Clin. Invest. 97, 2553-2561, doi: 10.1172/JCI118703 (1996).
25. Vidal-Puig, A. J. et al. Peroxisome proliferator-Activated receptor gene expression in human tissues. Effects of obesity, weight loss, and regulation by insulin and glucocorticoids. J. Clin. Invest. 99, 2416-2422, doi: 10.1172/JCI119424 (1997).
26. Hodson, L., Skeaff, C. M. & Fielding, B. A. Fatty acid composition of adipose tissue and blood in humans and its use as a biomarker of dietary intake. Prog. Lipid Res. 47, 348-380, doi: 10.1016/j.plipres.2008.03.003 (2008).
27. Rivera, J. A., Barquera, S., Gonzalez-Cossio, T., Olaiz, G. & Sepulveda, J. Nutrition transition in Mexico and in other Latin American countries. Nutr. Rev. 62, S149-157 (2004).
28. Daniels, S. R., Jacobson, M. S., McCrindle, B. W., Eckel, R. H. & Sanner, B. M. American Heart Association Childhood Obesity Research Summit Report. Circulation 119, e489-517, doi: 10.1161/CIRCULATIONAHA.109.192216 (2009).
29. Jenkins, D. J. et al. Effects of a dietary portfolio of cholesterol-lowering foods vs lovastatin on serum lipids and C-reactive protein. JAMA 290, 502-510, doi: 10.1001/jama.290.4.502 (2003).
30. Romero-Polvo, A. et al. Association between dietary patterns and insulin resistance in Mexican children and adolescents. Ann. Nutr. Metab. 61, 142-150, doi: 10.1159/000341493 (2012).
31. Lee, J. M., Okumura, M. J., Davis, M. M., Herman, W. H. & Gurney, J. G. Prevalence and determinants of insulin resistance among U.S. adolescents: a population-based study. Diabetes Care 29, 2427-2432, doi: 10.2337/dc06-0709 (2006).
32. Aguirre-Arenas, J., Escobar-Perez, M. & Chavez-Villasana, A. [Evaluation of food consumption patterns and nutrition in 4 rural communities]. Salud Publica Mex. 40, 398-407 (1998).
33. Juarez-Rojas, J. G. et al. Blood pressure and associated cardiovascular risk factors in adolescents of Mexico City. Arch Cardiol. Mex. 78, 384-391 (2008).
34. Dyson, P. A. et al. High rates of child hypertension associated with obesity: a community survey in China, India and Mexico. Paediatr Int Child Health 34, 43-49, doi: 10.1179/2046905513Y.0000000079 (2014).
35. Ramos-Arellano, L. E. et al. Body fat distribution and its association with hypertension in a sample of Mexican children. J. Investig. Med. 59, 1116-1120, doi: 10.231/JIM.0b013e31822a29e1 (2011).
36. Xu, H. E. et al. Molecular recognition of fatty acids by peroxisome proliferator-Activated receptors. Mol. Cell 3, 397-403 (1999).
37. McLaughlin, T. et al. Use of metabolic markers to identify overweight individuals who are insulin resistant. Ann. Intern. Med. 139, 802-809 (2003).
38. Kubota, N. et al. PPAR gamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance. Mol. Cell 4, 597-609 (1999).
39. Wang, H. & Peng, D. Q. New insights into the mechanism of low high-density lipoprotein cholesterol in obesity. Lipids Health Dis. 10, 176, doi: 10.1186/1476-511X-10-176 (2011).
40. Bonvecchio, A. et al. Overweight and obesity trends in Mexican children 2 to 18 years of age from 1988 to 2006. Salud Publica Mex. 51 Suppl 4, S586-594 (2009).
41. Martinez-Marignac, V. L. et al. Admixture in Mexico City: implications for admixture mapping of type 2 diabetes genetic risk factors. Hum. Genet. 120, 807-819, doi: 10.1007/s00439-006-0273-3 (2007).
42. Matthews, D. R. et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412-419 (1985).
43. Garcia Cuartero, B. et al. [The HOMA and QUICKI indexes, and insulin and C-peptide levels in healthy children. Cut off points to identify metabolic syndrome in healthy children]. An. Pediatr. (Barc.) 66, 481-490 (2007).
44. Kavey, R. E. et al. American Heart Association guidelines for primary prevention of atherosclerotic cardiovascular disease beginning in childhood. Circulation 107, 1562-1566 (2003).
45. Kalra, S., Gandhi, A., Kalra, B. & Agrawal, N. Management of dyslipidemia in children. Diabetol. Metab. Syndr. 1, 26, doi: 10.1186/1758-5996-1-26 (2009).